Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis

The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections

(2016) Inonge van Twillert et al.   PLoS One

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12–23 Months Following Meningococcal Vaccination

(2015) Daniel Holme et al.   CLINICAL INFECTIOUS DISEASES

Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity

(2015) René H. M. Raeven et al.   JOURNAL OF PROTEOME RESEARCH

Cooperative Roles for Fimbria and Filamentous Hemagglutinin in Bordetella Adherence and Immune Modulation

(2015) Erich V. Scheller et al.   mBio

Roads to the development of improved pertussis vaccines paved by immunology

(2015) Jolanda Brummelman et al.   Pathogens and Disease

Contribution of pertussis toxin to the pathogenesis of pertussis disease: Graphical Abstract Figure.

(2015) Nicholas H. Carbonetti   Pathogens and Disease

Waning and aging of cellular immunity toB. pertussis

(2015) Inonge van Twillert et al.   Pathogens and Disease

Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage

(2014) S. W. Martin et al.   CLINICAL INFECTIOUS DISEASES

The Unexplored Roles of Human Serum IgA

(2014) Ka Wai Leong et al.   DNA AND CELL BIOLOGY

Bordetella pertussisfimbriae (Fim): relevance for vaccines

(2014) Andrew R Gorringe et al.   Expert Review of Vaccines

Age Related Differences in Dynamics of Specific Memory B Cell Populations after Clinical Pertussis Infection

(2014) Inonge van Twillert et al.   PLoS One

IgG Subclasses and Allotypes: From Structure to Effector Functions

(2014) Gestur Vidarsson et al.   Frontiers in Immunology

Aging Promotes Progression of IgA Nephropathy: A Systematic Review and Meta-Analysis

(2013) Zhi-Yu Duan et al.   AMERICAN JOURNAL OF NEPHROLOGY

The Virulence Factors of Bordetella pertussis: Talented Modulators of Host Immune Response

(2013) Giorgio Fedele et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Complex Correlates of Protection After Vaccination

(2013) S. A. Plotkin   CLINICAL INFECTIOUS DISEASES

Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort

(2013) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay

(2013) N. K. Fry et al.   JOURNAL OF MEDICAL MICROBIOLOGY

A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens

(2013) G.A.M. Berbers et al.   VACCINE

Age-Related Differences in Patterns of Increased Bordetella pertussis Antibodies

(2012) Harry E. Prince et al.   Clinical and Vaccine Immunology

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps

(2012) Marjolein van Gent et al.   PLoS One

Prospective Evaluation of an Australian Pertussis Toxin IgG and IgA Enzyme Immunoassay

(2011) Meryta L. May et al.   Clinical and Vaccine Immunology

The ins and outs of pertussis toxin

(2011) Camille Locht et al.   FEBS Journal

Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children

(2011) Lotte H. Hendrikx et al.   VACCINE

Pertussis toxin and adenylate cyclase toxin: key virulence factors ofBordetella pertussisand cell biology tools

(2010) Nicholas H Carbonetti   Future Microbiology

Structure and function of immunoglobulins

(2010) Harry W. Schroeder et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine

(2010) T. Dalby et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection

(2009) HANS O. HALLANDER et al.   APMIS

Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination withBordetella pertussisin young children

(2009) HANS O. HALLANDER et al.   APMIS

Immunoglobulin G4: an odd antibody

(2009) R. C. Aalberse et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Pathology and Pathogenesis of FatalBordetella pertussisInfection in Infants

(2008) Christopher D. Paddock et al.   CLINICAL INFECTIOUS DISEASES

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus

(2008) Pieter G.M. van Gageldonk et al.   JOURNAL OF IMMUNOLOGICAL METHODS